VaxThera Secures Vaccine Manufacturing Agreement

On 2 November, South Korea’s GC Biopharma signed a 59.2 billion won agreement with Colombia’s VaxThera for influenza-vaccine materials and production expertise. The deal creates opportunities in pharmaceutical manufacturing, packaging and distribution. HPC can help identify qualified healthcare suppliers and commercial partners.

If you are interested to enquire further, please fill in the form below with your details and one of our consultants will contact you shortly.